Micafungin

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2327 publications

Candidozyma auris susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents.

Candidozyma auris susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents.

Journal: JAC-antimicrobial resistance
Published: May 29, 2026

Impact of a Pharmacy-Driven (1,3)-β-D-Glucan Algorithm on Micafungin Duration of Therapy in the ICU.

Impact of a Pharmacy-Driven (1,3)-β-D-Glucan Algorithm on Micafungin Duration of Therapy in the ICU.

Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: May 26, 2026

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of Aspergillus fumigatus to echinocandins with the EUCAST E.Def 9.4.

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of Aspergillus fumigatus to echinocandins with the EUCAST E.Def 9.4.

Journal: Journal of clinical microbiology
Published: May 22, 2026

Evaluation of Sensititre YeastOne for antifungal susceptibility testing of Candida (Candidozyma) auris: misclassification of FKS1 mutants and overestimation of caspofungin resistance in a global collection of isolates.

Evaluation of Sensititre YeastOne for antifungal susceptibility testing of Candida (Candidozyma) auris: misclassification of FKS1 mutants and overestimation of caspofungin resistance in a global collection of isolates.

Journal: Journal of clinical microbiology
Published: May 14, 2026

Chronic invasive Aspergillus Fumigatus rhinosinusitis with intracranial extension.

Chronic invasive Aspergillus Fumigatus rhinosinusitis with intracranial extension.

Journal: IDCases
Published: May 07, 2026

Micafungin microevolution in Candida auris reveals resistance development without in vivo fitness compromise.

Micafungin microevolution in Candida auris reveals resistance development without in vivo fitness compromise.

Journal: Virulence
Published: April 29, 2026

Rasamsonia argillacea in Patient with Immunodeficiency: First Suspected Case in Türkiye

Rasamsonia argillacea in Patient with Immunodeficiency: First Suspected Case in Türkiye

Journal: Mikrobiyoloji bulteni
Published: April 27, 2026

Drug-resistant clinical Candida responded to 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in vitro via enhanced ROS release.

Drug-resistant clinical Candida responded to 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in vitro via enhanced ROS release.

Journal: Antimicrobial agents and chemotherapy
Published: April 17, 2026

Rare Invasive Fusarium Sinusitis in a Transiently Immunosuppressed Patient.

Rare Invasive Fusarium Sinusitis in a Transiently Immunosuppressed Patient.

Journal: Cureus
Published: April 07, 2026

Detecting healthcare-associated transmission and antifungal resistance in Candida auris via whole genome sequencing.

Detecting healthcare-associated transmission and antifungal resistance in Candida auris via whole genome sequencing.

Journal: Journal of clinical microbiology
Published: March 25, 2026

Quiescence improves Candida albicans survival of fungicidal drug exposure.

Quiescence improves Candida albicans survival of fungicidal drug exposure.

Journal: bioRxiv : the preprint server for biology
Published: March 11, 2026

Comparative efficacy and safety of antifungal prophylactic agents in allogeneic hematopoietic stem cell transplantation: A systematic review and network meta-analysis.

Comparative efficacy and safety of antifungal prophylactic agents in allogeneic hematopoietic stem cell transplantation: A systematic review and network meta-analysis.

Journal: International journal of antimicrobial agents
Published: March 04, 2026
Showing 1-12 of 2,327

Last Updated: 06/30/2026